Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124653963 | 12465396 | 3 | F | 20150625 | 20160706 | 20160614 | 20160713 | EXP | FR-SA-2016SA109967 | AVENTIS | 82.00 | YR | E | F | Y | 0.00000 | 20160713 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124653963 | 12465396 | 1 | SS | DIAMOX SEQUELS | ACETAZOLAMIDE | 1 | Oral | UNK | 0 | 1 | DF | QD | |||||||
| 124653963 | 12465396 | 2 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | 20839 | 1 | DF | FILM-COATED TABLET | QD | ||||||
| 124653963 | 12465396 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | 1000 | MG | QD | |||||||
| 124653963 | 12465396 | 4 | I | INEXIUM | ESOMEPRAZOLE | 1 | Oral | UNK | 0 | 1 | DF | GASTRO-RESISTANT GRANULES | QD | ||||||
| 124653963 | 12465396 | 5 | I | ALDACTONE | SPIRONOLACTONE | 1 | Oral | UNK | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||||
| 124653963 | 12465396 | 6 | C | IKOREL | NICORANDIL | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 124653963 | 12465396 | 7 | C | FUMAFER | FERROUS FUMARATE | 1 | Oral | 0 | 66 | MG | FILM-COATED TABLET | QD | |||||||
| 124653963 | 12465396 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 10 MG | 0 | 1 | DF | QD | |||||||
| 124653963 | 12465396 | 9 | C | ZAMUDOL | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG PROLONGED RELEASE CAPSULE | 0 | 1 | DF | CAPSULE | BID | ||||||
| 124653963 | 12465396 | 10 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 4000 ANTI-XA IU / 0.4 ML, SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | 0 | 1 | DF | QD | |||||||
| 124653963 | 12465396 | 11 | C | LASILIX | FUROSEMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124653963 | 12465396 | 1 | Cardiac failure |
| 124653963 | 12465396 | 2 | Ischaemic cardiomyopathy |
| 124653963 | 12465396 | 3 | Type 2 diabetes mellitus |
| 124653963 | 12465396 | 5 | Cardiac failure |
| 124653963 | 12465396 | 7 | Cardiac failure |
| 124653963 | 12465396 | 8 | Myocardial ischaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124653963 | 12465396 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124653963 | 12465396 | Drug interaction | |
| 124653963 | 12465396 | Metabolic acidosis | |
| 124653963 | 12465396 | Off label use | |
| 124653963 | 12465396 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124653963 | 12465396 | 1 | 201506 | 0 | ||
| 124653963 | 12465396 | 5 | 201506 | 0 | ||
| 124653963 | 12465396 | 11 | 201506 | 0 |